Cardiovascular disease is one of the main causes of death in developed countries. Several factors are involved in its appearance and progress, among which nutrition enjoys a certain protagonism. Until recently, the dietetic criteria for preventing and controlling cardiovascular disease were mainly restrictive (at least in terms of energy and fat intake), but such advice is difficult to follow, and without careful monitoring can lead to deficiencies that might negatively affect quality of life and perhaps even life expectancy. Several investigations show that some components of the lipid fraction of the diet, such as o-3 fatty acids, are beneficial with respect to cardiovascular disease, and these have become the centre of much attention. This paper reviews the results of some of these studies and evaluates the benefit of these fatty acids in the prevention of coronary heart disease. The sources of o-3 fatty acids, their recommended consumption, possible mechanisms of action and potential adverse effects are discussed.
Introduction
Interest in o-3 fatty acids began when it was discovered that mortality from myocardial infarction (MI) among Greenland Eskimos was significantly lower than among the Danes, even though the former group consumed large quantities of fats and cholesterol. Eventually, it was found that the Eskimo diet was richer in o-3 and monounsaturated fatty acids of marine origin, and that Eskimos also consumed less o-6 fatty acids and saturated fat. Since then, several studies have suggested that fish consumption is associated with a reduction in cardiovascular mortality (Carroll & Roth, 2002) . This hypothesis led to research by many authors into the possible antiatherogenic effects of o-3 polyunsaturated fatty acids (PUFAs).
Epidemiological and clinical evidence
The majority of available epidemiological and clinical data (Albert et al, 1998 GISSI-Prevenzione Investigators, 1999; He et al, 2002; Hu et al, 2002) suggest that o-3 fatty acids have a beneficial effect on coronary heart disease mortality. Hu et al (2002) studied a group of 84 688 women enrolled in the Nurses' Health Study, all of whom were registered nurses aged 30-55 y and were free from cardiovascular disease and cancer at baseline in 1980. During the 16-y follow-up, a significant inverse association between fish intake and incidence of coronary heart disease was observed.
The Physicians' Health Study (Albert et al, 1998 ) evaluated the diet of 20 551 male physicians aged 40-84 y who had no history of MI, stroke, transient ischaemic attack or cancer. Over an 11-y follow-up period, it was observed that fish consumption was inversely related to the risk of sudden cardiac death. This relationship reached significance at a consumption level of between 1 and 2 servings per week. No additional reduction in risk was seen for greater fish intake.
Later, Albert et al (2002) performed a prospective, nested, case-control analysis of whole blood fatty acid composition in a subset of the above subjects. These authors identified 94 subjects in whom sudden death was the first manifestation of cardiovascular disease. A group of 184 matched controls with no confirmed history of cardiovascular disease was identified from the same population. After adjustment for potential confounding factors, baseline blood levels of o-3 PUFA were inversely related to the risk of sudden death. Although a single analysis of fatty acids might not reflect their long-term consumption, and despite the fact that the authors used whole blood instead of plasma or red blood cells, the data collected contribute to the growing body of evidence suggesting that long-chain o-3 fatty acids from fish may reduce the risk of sudden death from cardiac causes, even among men without a history of cardiovascular disease.
Over a 12 y period, He et al (2002) studied the relationship between fish consumption and long-chain o-3 PUFA intake and the risk of stroke in 43 671 men aged 40-75 y who were free of cardiovascular disease at baseline in 1986. Compared to men who consumed fish less than once per month, the multivariate RR of ischaemic stroke was significantly lower in those who ate fish 1-3 times per month. However, a higher frequency of fish intake was not associated with further risk reduction.
The GISSI-Prevenzione trial, a large-scale clinical intervention, included 11 323 patients that survived a recent MI (o3 months) and were randomly assigned to supplements of o-3 PUFA (1 g daily, n ¼ 2836), vitamin E (300 mg daily, n ¼ 2830), both (n ¼ 2830), or placebo (n ¼ 2828), in addition to optimal pharmacological treatment and lifestyle advice (GISSI-Prevenzione Investigators, 1999). After 3.5 y, treatment with o-3 fatty acids produced a significant reduction in the cumulative rate of all-cause death and nonfatal MI. No additional benefit in total mortality, cardiac death or sudden death was seen for those who consumed o-3 fatty acid and/or vitamin E (GISSI-Prevenzione investigators, 1999).
A cohort study of adults aged Z65 y showed that a greater, combined dietary intake of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), and possibly of a-linolenic acid (ALA), might lower the risk of fatal ischaemic heart disease in older adults (Lemaitre et al, 2003) .
The Lyon Heart Study (de Lorgeril et al, 1999) was an intervention trial involving 605 survivors of first MI, of whom 303 were randomised to be control patients and 302 were advised to change their diet to one that was more Mediterranean-style. This Mediterranean diet consisted of consuming more bread, more vegetables, more fish, less meat, there being no day without fruit, and in which butter and cream were replaced with margarine supplied by the study organisers. The margarine had a composition comparable to olive oil, however, it was slightly richer in linoleic acid (16.4% vs 8.6%) and rather more rich in ALA (4.8% vs 0.6%). In the experimental group, the relative risk of MIcaused death was 0.44, that of cardiac death and nonfatal Ml was 0.28, while other clinical events such as unstable angina, heart failure, and stroke were also less frequently observed. In multivariate analysis, ALA was the only fatty acid significantly associated with a reduction in the risk of cardiac death and nonfatal MI.
Possible mechanisms of cardioprotective effects
Several authors have reported the important role of dietary o-3 PUFAs in reducing circulating levels of triglycerides (Carroll & Roth, 2002 ) F an independent risk factor for heart disease (Braunwald et al, 2001) . But o-3 fatty acids have beneficial effects on cardiovascular disease beyond their influence on plasma lipoproteins.
Long-chain o-3 PUFAs decrease platelet aggregation capacity through the inhibition of thromboxane A2 synthesis and also modify the deformation capacity of red blood cells. These effects are a consequence of changes in cell membrane fatty acid composition (He et al, 2002) .
Another proposed mechanism involved in cardiovascular protection is the ability of o-3 fatty acids to improve endothelial function (Mori & Beilin, 2001; Carroll & Roth, 2002) . This is partly accomplished through enhanced production of nitric oxide. Vasodilation may also be accomplished by the blockage of calcium entry into vascular smooth muscle, suppression of vasoconstrictor prostanoids, and reduced plasma norepinephrine (Mori & Beilin, 2001) , mechanisms that favour the control of arterial blood pressure, another important risk factor for cardiovascular disease. o-3 fatty acids possibly exert cardiovascular benefits through their effects on genes encoding proteins involved in the upregulation of lipid oxidation and downregulation of lipid synthesis (Carroll & Roth, 2002) .
However, the most important effects of o-3 fatty acids are due to the prevention of arrhythmias and sudden death (Jones, 2002; Lemaitre et al, 2003) . It is thought that about half of all coronary deaths are caused by electrical instability of the myocardium which leads to ventricular fibrillation. Some studies have shown that polyunsaturated o-3 fatty acids have antiarrhythmia properties. The mechanism underlying this effect lies in the capacity of these fatty acids to electrically stabilise the contraction of the cardiac muscle (Albert et al, 1998; Kang & Leaf, 2000; Mori & Beilin, 2001; Carroll & Roth, 2002) .
Sources of x-3 fatty acids
The consumption of a variety of fish species including halibut, mackerel, herring and salmon is among the best ways to ensure a good intake of o-3 fatty acids. Several o-3 fatty acid supplements are also available, but these provide varying amounts of marine-based EPA and DHA (Carroll & Roth, 2002; von Schacky, 2003) . However, a-ALA, which serves as a precursor of EPA, is also a polyunsaturated o-3 fatty acid, and is found primarily in plant products such as soybeans, canola oil, flaxseed oil, and leafy vegetables (Roche, 1999) . In a number of epidemiological studies, the consumption of food rich in ALA was found to be correlated with reduced morbidity and mortality from cardiovascular causes (de Lorgeril et al, 1999; Djoussé et al, 2001; von Schacky, 2003) .
Potential adverse effects
Very high doses (420 g/day) of o-3 fatty acids might be associated with increased bleeding times. However, moderate consumption (2-5 g/day) does not appear to cause this (Eritsland, 2000) . Epidemiological data on this are sparse because most studies have not separated ischaemic from haemorrhagic stroke due either to the small number of haemorrhagic events or incomplete clinical information. In the Nurses' Health Study, Iso et al (2001) found a significant inverse association between fish intake and the risk of thrombotic, but not haemorrhagic, stroke. He et al (2002) found no significant association between fish or long-chain omega-3 PUFA consumption and the risk of haemorrhagic stroke, but indicate that more research is required in this area.
The consumption of o-3 fatty acids, especially in higher doses, may slightly raise serum LDL concentrations (Carroll & Roth, 2002) , although this increase is generally o5%. If increases in LDL persist, or concentrations continue to rise in the presence of beneficial effects from o-3 fatty acid supplementation, the administration of an HMG-CoA reductase inhibitor is a safe and effective strategy for offsetting this rise (Davidson et al, 1997) .
The most common adverse effects reported (Carroll & Roth, 2002) by patients include gastrointestinal discomfort, nausea, and a 'fishy taste in the mouth,' which is commonly associated with belching, bloating, and an stomach upset.
Consumption criteria
It is important to note that reductions in cardiovascular mortality have been achieved with smaller quantities of o-3 fatty acids (EPA/DHA 360-850 mg/day) than with those required to achieve significant reductions in triglycerides (EPA/DHA 3-4 g/day) (Albert et al, 1998; GISSI Prevenzione Investigators, 1999; Albert et al, 2002; Carroll & Roth, 2002; Hu et al, 2002) .
Although formal dose-finding studies are extremely difficult to conduct for EPA plus DHA, a dose of between 0.85 and 1.5 g/day of EPA plus DHA (1-2 fish meals/week) appears to be effective and safe (von Schacky, 2003) . Other bodies advise that linoleic and linolenic acids should supply between 3-5% and 0.5-1% of energy intake respectively (Jones & Papamandjaris, 2001) .
Several investigators suggests a need for achieving a desirable o-6:o-3 ratio for optimal health benefit: 5:1-10:1 appears to be the best for reducing cardiovascular mortality (Hu, 2001) .
o-3 fatty acids may be beneficial and their administration to patients with documented coronary heart disease should be considered. This is especially true for patients who have risk factors for sudden cardiac death such as prior MI, leftventricular dysfunction, ventricular dysrhythmias, or leftventricular hypertrophy. For the primary prevention of heart disease, it is reasonable to recommend that patients incorporate at least two fish-containing meals per week into their diets (Krauss et al, 2000; von Schacky, 2003) .
More studies are needed to determine a correct dosage, while others are needed in which the pre-experimental nutritional status of subjects is determined. It may be that people with worse food habits consume less fish; correcting this would be particularly beneficial. Extra vitamin E might also be beneficial depending on the nutritional and health status of the population in question.
Conclusion
It is evident that an important cardiac-regulating function exists that is affected by o-3 PUFAs, influenced by simple dietary choices, and that has largely escaped the attention of researchers and cardiologists (Kang & Leaf, 2000) . o-3 PUFAs have always been an essential component of human diets and could provide simple and safe protection against different types of cardiovascular disease the main cause of death in developed countries (American Heart Association, 1995). These PUFAs may therefore provide significant public health benefits.
Suggestive and provocative data now purport a role for dietary o-3 PUFAs, particularly EPA and DHA. These appear important not only in cardiovascular disease management but also in risk reduction for autoimmune disease, certain forms of cancer, diabetes and arthritis (Connor, 2000) . Increasing intakes of o-3 fatty acids, particularly the longer chain forms found in fish, could improve population health at low cost and little risk (Jones, 2002) .
